Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

Nav

General Info

Geography

Austria (AUT)

Time period covered

01/1997 - 12/2003

Data type

Scientific literature

Keywords

Ischemic heart disease

Citation

Authors

Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators

Journal

Lancet

Volume

362

Issue

9386

Pages

782–8

Publication year

2003

Suggested citation

Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003; 362(9386): 782–8.

GHDx Entry last modified on: Oct 8, 2022

Header sites

Search form

Main menu

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

Nav